ArticleFrontiers in oncology2026
Prediction of cervical stromal invasion using ultrasound radiomics: from conventional ultrasound to intelligent diagnosis.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale and objectives: Accurate preoperative assessment of cervical stromal invasion (CSI) in endometrial cancer (EC) is crucial for surgical planning, but conventional imaging has limited diagnostic performance. This study aims to develop and validate a non-invasive ultrasound radiomics model to improve the preoperative prediction accuracy of CSI. Materials and methods: We retrospectively analyzed 294 patients with pathologically confirmed EC, randomly assigned (7:3) to training (n=205) and test (n=89) cohorts. Regions of interest were manually segmented on 2D ultrasound images using 3D-Slicer, from which 837 radiomics features were extracted. Following screening for reproducibility (ICCs ≥ 0.75) and univariate analysis, the features were finally reduced to 25 via LASSO regression, and the radiomic score (Radscore) was calculated. Similarly, six clinical predictors (menopause duration, parity, CA-125, tumor size, endometrial-myometrial junction, vascularity grade) were identified via univariate analysis and LASSO regression and combined into a clinical score (C_score). Logistic regression was used to build radiomics, clinical, and combined nomogram models. Performance was assessed using AUC, calibration curves, and decision curve analysis (DCA). Results: The radiomics model achieved the highest AUCs: 0.975 (95% CI: 0.958-0.991) in the training cohort and 0.906 (95% CI: 0.848-0.965) in the test cohort, significantly outperforming the clinical model (AUC: 0.947 and 0.832) and the nomogram model (AUC: 0.945 and 0.838). Furthermore, it showed good calibration and provided substantial net clinical benefit across a wide range of threshold probabilities on DCA. Conclusion: Ultrasound radiomics is a promising non-invasive tool for preoperatively predicting CSI in EC, with potential to enhance personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.